Answers are grounded in this paper and cite their sources.
Cohort study reveals dynamic 24-hour lactate trajectories predict 28-day mortality in sepsis-associated ARDS, highlighting the value of longitudinal monitoring over single tests.
Static lactate levels inadequately reflect disease progression in sepsis-associated acute respiratory distress syndrome (SA-ARDS), which limits the accuracy of individualized prognostic assessment. This study aimed to identify the classification characteristics of 24-h dynamic lactate trajectories in SA-ARDS patients and evaluate their association with 28-day mortality. Using K-means clustering, we identified lactate trajectories in 931 SA-ARDS patients and validated in an independent MIMIC-IV cohort ( n = 621). Associations with mortality were assessed via multivariate regression, propensity score matching (PSM), and inverse probability treatment weighting (IPTW). Four trajectories emerged: plateau (Trajectory 1), decreasing (Trajectory 2), transient increase-then-decrease (Trajectory 3), and progressive hyperlactatemia (Trajectory 4). Mortality increased across trajectories (21.2% to 76.9%; P < 0.0001). Trajectories 3 (OR 2.53, 95% CI 1.10–5.90) and 4 (OR 6.73, 3.18–14.63) independently predicted mortality, confirmed in PSM and IPTW analyses. External validation and sensitivity analysis further supported the robustness of these findings replicated trajectory patterns and mortality associations. In SA-ARDS, 24-h lactate trajectories exhibit four distinct patterns, with Trajectories 3 and 4 independently predicting 28-day mortality. This approach supports risk stratification after the first 24-h observation period though its utility for immediate urgent clinical decision-making remains to be further investigated.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: